Journal of Clinical Medicine (Mar 2024)

Endoscopic Resection for Duodenal Neuroendocrine Neoplasms between 10 and 20 mm—A Systematic Review and Meta-Analysis

  • Roberta Elisa Rossi,
  • Benedetta Masoni,
  • Sara Massironi,
  • Giacomo Marcozzi,
  • Gianluca Franchellucci,
  • Angelo Zullo,
  • Antonio Facciorusso,
  • Silvia Carrara,
  • Nadim Mahmud,
  • Giulia Migliorisi,
  • Silvia Ferretti,
  • Roberta Maselli,
  • Cesare Hassan,
  • Alessandro Repici

DOI
https://doi.org/10.3390/jcm13051466
Journal volume & issue
Vol. 13, no. 5
p. 1466

Abstract

Read online

Background. The optimal management of duodenal neuroendocrine neoplasms (dNENs) sized 10–20 mm remains controversial and although endoscopic resection is increasingly performed instead of surgery, the therapeutic approach in this setting is not fully standardized. We performed a systematic review of the literature and a meta-analysis to clarify the outcomes of endoscopic resection for 10–20 mm dNENs in terms of efficacy (i.e., recurrence rate) and safety. Methods. A computerized literature search was performed using relevant keywords to identify pertinent articles published until January 2023. Results. Seven retrospective studies were included in this systematic review. The overall recurrence rate was 14.6% (95%CI 5.4–27.4) in 65 patients analyzed, without significant heterogeneity. When considering studies specifically focused on endoscopic mucosal resection, the recurrence rate was 20.5% (95%CI 10.7–32.4), without significant heterogeneity. The ability to obtain the free margin after endoscopic resection ranged between 36% and 100%. No complications were observed in the four studies reporting this information. Conclusions. Endoscopic resection could be the first treatment option in patients with dNENs sized 10–20 mm and without evidence of metastatic disease. Further studies are needed to draw more solid conclusions, particularly in terms of superiority among the available endoscopic techniques.

Keywords